AC
BSTC

Armistice Capital’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Armistice Capital’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-105,000
Closed -$4.05M – 31
2014
Q4 		$4.05M Buy
+105,000
New +$4.01M 1.95% 23

Other funds holding BSTC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Armistice Capital's BSTC Position: Q1 2015 in Review

Armistice Capital sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2015, closing a stake of 105,000 shares — an estimated $4.05M sold.

Armistice Capital first reported a position in BSTC in Q4 2014 and held it in 1 quarter. The position peaked at $4.05M in Q4 2014. 79 funds tracked by Wall St. Rank hold BSTC as of Q1 2015.

  • Armistice Capital reported no remaining BioSpecifics Technologies Corp. position as of Q1 2015 after selling out during the quarter.
  • Armistice Capital sold 105,000 BioSpecifics Technologies Corp. shares in Q1 2015, an estimated $4.05M.
  • Armistice Capital first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 1 quarter.
  • Armistice Capital's BioSpecifics Technologies Corp. position peaked at $4.05M in Q4 2014.
  • 79 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2015.

Based on Armistice Capital's 13F filing for Q1 2015, filed 15 May 2015.